Pages that link to "Q42270394"
Jump to navigation
Jump to search
The following pages link to Radiation therapy to convert the tumor into an in situ vaccine (Q42270394):
Displaying 50 items.
- Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored (Q26865395) (← links)
- Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy (Q27001216) (← links)
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy (Q27004011) (← links)
- Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival (Q33859105) (← links)
- Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model (Q33930599) (← links)
- Combinations of immunotherapy and radiation in cancer therapy. (Q34582640) (← links)
- Update on treatment of liver metastases: focus on ablation therapies (Q35443517) (← links)
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity (Q35908369) (← links)
- Immunology and Immunotherapy of Head and Neck Cancer (Q36100837) (← links)
- Radiation as an immunological adjuvant: current evidence on dose and fractionation. (Q36347177) (← links)
- Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously (Q36356635) (← links)
- Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma (Q36936587) (← links)
- Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era (Q37118895) (← links)
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications (Q37308207) (← links)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (Q37533025) (← links)
- TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy (Q37567832) (← links)
- The Immunoregulatory Potential of Particle Radiation in Cancer Therapy (Q37625801) (← links)
- Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? (Q38110978) (← links)
- Immune modulation and stereotactic radiation: improving local and abscopal responses. (Q38170122) (← links)
- Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors (Q38218134) (← links)
- Advances in local and ablative treatment of oligometastasis in prostate cancer (Q38243113) (← links)
- Combining immunotherapy with radiation for the treatment of glioblastoma (Q38422623) (← links)
- Strategies to relieve immunosuppression in pancreatic cancer. (Q38445328) (← links)
- Opportunities and challenges of radiotherapy for treating cancer (Q38539957) (← links)
- Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways (Q38541699) (← links)
- In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment (Q38543250) (← links)
- Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review. (Q38548397) (← links)
- Should we be combining local tumor therapies with immunotherapies as standard? (Q38638858) (← links)
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. (Q38760078) (← links)
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? (Q38763935) (← links)
- Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer. (Q38771934) (← links)
- Emerging Opportunities and Challenges in Cancer Immunotherapy. (Q38809772) (← links)
- Combinatorial immunotherapy for melanoma (Q39005199) (← links)
- Radiotherapy and immunotherapy: a beneficial liaison? (Q39017268) (← links)
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. (Q39130461) (← links)
- Barriers to Radiation-Induced In Situ Tumor Vaccination. (Q39203685) (← links)
- Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors (Q39208496) (← links)
- Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma (Q41334725) (← links)
- High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma (Q41902106) (← links)
- Consensus guidelines for the detection of immunogenic cell death (Q42553556) (← links)
- Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). (Q43084076) (← links)
- Radiation and Anti-Cancer Vaccines: A Winning Combination (Q47547584) (← links)
- Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. (Q47899811) (← links)
- Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. (Q48193685) (← links)
- Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop (Q49571153) (← links)
- Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors (Q50044559) (← links)
- Retuning the Radio in Radiobiology. (Q50067855) (← links)
- Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. (Q51737223) (← links)
- Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer? (Q52718920) (← links)
- Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants. (Q52723401) (← links)